The FDA could approve the first blood test that can detect multiple cancers, around the end of the year, setting the stage for it to become widely available.

Freenome, an early cancer detection company developing blood-based screening tests, today announced favorable results from its pivotal clinical validation study assessing the performance of assay and ...

Bernstein lifted its Guardant Health price target to $200 after UnitedHealth's Shield coverage decision. Here's what it means ...

Q: I am 77. My brother died of prostate cancer. My doctor says I don’t need PSA testing at my age. But because my brother ...

A new blood test was found to detect colon cancer with more than 80% accuracy — and to rule it out for 90% of healthy people. The results were presented at the 2025 American Society of Clinical ...

New research has uncovered persistent disparities in preventive cancer care across different sexual orientation and gender ...

Stockholm3 blood test detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests in a study of over ...

Some claim the new multi-cancer detection tests will “revolutionize” cancer screening. Others fear the “worried well” will succumb to slick marketing and subpar tests and overwhelm both primary care ...

More patients in primary care practices with vs. without access to a blood-based lung cancer screening test received ...

A study reveals significant disparities in cancer screening rates among sexual and gender minorities, highlighting the need ...

Colorectal cancer screening can help your doctor find and remove precancerous polyps before they become cancer or find colorectal cancer early when it’s most treatable. Colorectal cancer screening ...

Rates of prostate cancer screening shared decision-making (SDM) are very low in family medicine practices, according to a study published in the June issue of the Southern Medical Journal. Nicholas ...